American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer.

American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer.

Item
http://www.wikidata.org/entity/Q34638008
Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literatureZoledronate effects on systemic and jaw osteopenias in ovariectomized periostin-deficient miceSide effects of bone-targeted therapies in advanced breast cancer.De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists.Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey.Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) projectRisk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor.N-Telopeptide of Type I Collagen Long-Term Dynamics in Breast Cancer Patients With Bone Metastases: Clinical Outcomes and Influence of Extraskeletal Metastases.Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.Expert opinion 2011 on the use of new anti-resorptive agents in the prevention of skeletal-related events in metastatic bone disease.Denosumab versus zoledronic acid to prevent aromatase inhibitors-associated fractures in postmenopausal early breast cancer; a mixed treatment meta-analysis.
P2860

American society of clinical oncology clinical practice guideline update: recommendations on the role of bone-modifying agents in metastatic breast cancer.

Item
http://www.wikidata.org/entity/Q34638008
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
American society of clinical o ...... s in metastatic breast cancer.
@ast
American society of clinical o ...... s in metastatic breast cancer.
@en
American society of clinical o ...... s in metastatic breast cancer.
@nl
type
label
American society of clinical o ...... s in metastatic breast cancer.
@ast
American society of clinical o ...... s in metastatic breast cancer.
@en
American society of clinical o ...... s in metastatic breast cancer.
@nl
prefLabel
American society of clinical o ...... s in metastatic breast cancer.
@ast
American society of clinical o ...... s in metastatic breast cancer.
@en
American society of clinical o ...... s in metastatic breast cancer.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
American society of clinical o ...... s in metastatic breast cancer.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932